
Brown & Brown Financial Ratios 2025-2007 | BRO
Brief overview of Brown & Brown's financial ratios
The review covers five available annual periods spanning 2019 to 2023.
Key multiples at the end of the period are P/E 26.98x (median 26.98x), P/B 1.58x (median 1.58x), P/CF 23.26x (median 20.43x). The multiple basket looks neutral against its history, differing from median levels by roughly 0%.
The 1/P/E calculation produces a 3.7% earnings yield. It does not capture future growth or capital structure.
Returns on assets and capital are represented by ROE 15.6%, ROA 5.8%, ROCE 10.3%. Current resource returns are convincing and help explain a higher market valuation.
Price, earnings and growth produce a PEG of 2.14x. A high value reduces the cushion if growth slows.
Financial-company multiples cannot be compared directly with industrial businesses; P/B and sustainable capital returns remain central.
Conclusion
Brown & Brown trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios Brown & Brown
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
33.4 | 25.2 | 27.0 | 23.3 | 31.1 | 24.3 | 31.0 | 21.1 | 18.0 | 22.4 | 17.1 | 21.0 | 20.7 | 20.7 | 19.3 | 8.3 | 8.8 | 8.0 | - |
P/S |
6.0 | 5.2 | 5.5 | 4.4 | 6.0 | 4.5 | 5.2 | 3.6 | 3.9 | 3.3 | 2.5 | 2.8 | 3.3 | 3.2 | 3.1 | 1.4 | 1.4 | 1.4 | - |
EPS |
3.4 | 3.5 | 3.1 | 2.4 | 2.1 | 1.7 | 1.4 | 1.2 | 1.4 | 0.9 | 1.7 | 1.4 | 1.5 | 1.3 | 1.1 | 1.1 | 1.1 | 1.2 | - |
EV (Enterprise Value) |
34.1 B | 24.4 B | 22.8 B | 15 B | 17.5 B | 11 B | 16.1 B | 10.5 B | 9.8 B | 8.18 B | 6.59 B | 6.72 B | 5.93 B | 4.91 B | 3.84 B | 1.06 B | 1.14 B | 1.25 B | -38.2 M |
EBITDA per Share |
0.18 | 0.16 | 0.14 | 0.14 | 0.12 | 0.1 | 2.57 | 2.25 | 2.21 | 2.12 | 2 | 1.88 | 1.64 | 1.44 | 1.26 | 0.09 | 0.1 | 0.1 | - |
EV/EBITDA |
619.5 | 554.4 | 570.4 | 384.5 | -26.1 | 16.3 | 19.1 | 13.6 | 12.6 | 11.0 | 8.8 | 9.6 | 10.3 | 10.1 | 8.9 | 84.0 | 86.4 | 94.0 | - |
PEG |
2.63 | -2.79 | -2.99 | -2.7 | -2.79 | -1.74 | 2.14 | -1.59 | 0.33 | 3.21 | 0.84 | -4.5 | 1.2 | 1.83 | 21.99 | - | - | - | - |
P/B |
1.2 | 1.4 | 1.6 | 1.1 | 1.9 | 1.3 | 3.7 | 2.4 | 2.8 | 2.4 | 1.9 | 2.1 | 2.2 | 2.1 | 1.9 | 0.6 | 0.6 | - | - |
P/CF |
24.2 | 21.4 | 23.3 | 17.8 | 22.5 | 16.4 | 20.4 | 13.8 | 17.2 | 16.1 | 10.6 | 12.1 | 12.0 | 19.4 | 14.1 | 4.5 | 6.1 | 3.9 | - |
ROE % |
8.38 | 15.43 | 15.61 | 14.59 | 13.99 | 12.80 | 11.89 | 11.47 | 15.47 | 10.91 | 11.32 | 9.79 | 10.82 | 10.18 | 9.98 | 10.74 | 11.19 | 13.38 | - |
ROA % |
3.51 | 5.64 | 5.85 | 4.81 | 5.99 | 5.36 | 5.23 | 5.15 | 6.95 | 4.87 | 4.85 | 4.17 | 5.95 | 5.88 | 6.29 | 6.74 | 6.89 | - | - |
ROCE % |
- | - | - | - | - | - | 10.26 | 10.21 | 13.12 | 12.22 | 12.03 | 11.52 | 13.71 | 12.56 | 13.29 | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | 1.2 | 1.0 | 1.3 | 1.5 | - | - | - | - |
DSO |
- | - | - | - | - | - | 153.3 | 165.3 | 201.3 | 120.2 | 102.6 | 101.9 | 106.6 | 92.9 | 86.5 | - | - | - | - |
DPO |
- | - | - | - | - | - | 310.9 | 322.7 | 275.0 | 282.9 | 277.0 | 288.3 | 303.8 | 273.1 | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 153.3 | 165.3 | 201.3 | 120.2 | 102.6 | 101.9 | 106.6 | 92.9 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | -157.6 | -157.4 | -73.7 | -162.7 | -174.4 | -186.4 | -197.2 | -180.1 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Brown & Brown
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.86 | 1.27 | - | 0.68 | 0.79 | 1.16 | - | 0.82 | 0.9 | 1.03 | - | 0.62 | 0.67 | - | - | 0.57 | 0.51 | 0.78 | - | 0.52 | 0.49 | 0.71 | 0.34 | 0.47 | 0.34 | 0.54 | 0.27 | 0.41 | 0.33 | 0.41 | 0.26 | 0.38 | 0.27 | 0.33 | 0.0068 | 0.0027 | 0.0024 | 0.0025 | 0.0041 | 0.0051 | 0.0047 | 0.0045 | 0.0041 | 0.48 | 0.43 | 0.4 | 0.0017 | 0.47 | 0.43 | 0.0036 | 0.32 | 0.4 | 0.36 | 0.42 | 0.3 | 0.34 | 0.3 | 0.34 | 0.25 | 0.31 | 0.26 | 0.32 | 0.31 | - |
EBITDA per Share |
0.05 | 0.05 | - | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 | - | - | 0.04 | 0.03 | 0.03 | - | 0.03 | 0.03 | 0.03 | - | 0.02 | 0.02 | 0.02 | - | 0.02 | 0.02 | 0.02 | - | 0.02 | 0.02 | 0.02 | - | 0.02 | 0.02 | 0.02 | - | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 | 0.04 | - | 0.04 | 0.04 | 0.03 | - | 0.03 | 0.03 | 0.03 | - | 0.03 | 0.03 | 0.03 | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
ROE % |
9.48 | 12.03 | 8.66 | 12.27 | 14.70 | 17.77 | 12.93 | 16.32 | 16.45 | 17.05 | 11.99 | 15.73 | 15.73 | 17.07 | 12.21 | 15.77 | 15.57 | 17.39 | 12.31 | 14.90 | 14.90 | 13.95 | 12.80 | 12.49 | 12.37 | 12.55 | 11.89 | 12.06 | 12.15 | 11.85 | 11.47 | 16.29 | 15.69 | 15.79 | 15.47 | 10.65 | 10.75 | 10.99 | 10.91 | 11.16 | 11.27 | 11.30 | 11.32 | 9.78 | 9.87 | 9.96 | 9.79 | 10.99 | 10.63 | 10.30 | 10.82 | 10.82 | 10.69 | 10.44 | 10.18 | 10.04 | 9.99 | 9.89 | 9.98 | 10.75 | 10.92 | 2.82 | 2.99 | 2.86 |
ROA % |
4.07 | 5.08 | 3.65 | 4.98 | 5.82 | 6.18 | 4.21 | 5.56 | 5.40 | 3.79 | 3.79 | 4.97 | 5.67 | 4.32 | 4.32 | 5.84 | 6.15 | 7.20 | 5.25 | 6.34 | 6.31 | 5.90 | 5.36 | 5.28 | 5.30 | 5.43 | 5.23 | 5.32 | 5.39 | 5.28 | 5.15 | 7.31 | 7.05 | 7.09 | 6.95 | 4.79 | 4.82 | 4.93 | 4.89 | 4.96 | 4.95 | 4.91 | 4.87 | 4.20 | 4.23 | 4.25 | 4.17 | 4.98 | 5.18 | 5.36 | 5.95 | 6.02 | 6.02 | 5.95 | 5.88 | 5.92 | 6.03 | 6.10 | 6.29 | 6.75 | 6.81 | 1.78 | 1.85 | 1.76 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.8 | 1.8 | 1.8 | 1.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Brown & Brown, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Insurance brokers industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
BRP Group
BRP
|
- | -4.43 % | $ 1.81 B | ||
|
Fanhua
FANH
|
- | -0.65 % | $ 1.64 B | ||
|
GoHealth
GOCO
|
- | - | $ 4.01 M | ||
|
CorVel Corporation
CRVL
|
$ 68.68 | 0.93 % | $ 3.52 B | ||
|
Willis Towers Watson Public Limited Company
WLTW
|
- | -0.49 % | $ 28.8 B | ||
|
eHealth
EHTH
|
$ 0.95 | 0.31 % | $ 29 M | ||
|
Marsh & McLennan Companies
MMC
|
- | - | $ 89.6 B | ||
|
Huize Holding Limited
HUIZ
|
$ 1.44 | 0.34 % | $ 1.45 B | ||
|
Arthur J. Gallagher & Co.
AJG
|
$ 266.66 | 0.76 % | $ 68.3 B | ||
|
SelectQuote
SLQT
|
$ 0.54 | 1.24 % | $ 102 M | ||
|
Erie Indemnity Company
ERIE
|
$ 258.37 | 0.21 % | $ 13.5 B | ||
|
Aon PLC
AON
|
$ 327.0 | 1.4 % | $ 70.6 B |